Multidrug resistance-associated protein 2 is involved in the efflux of Aconitum alkaloids determined by MRP2-MDCKII cells

被引:18
作者
Dai, Peimin [1 ,2 ]
Zhu, Lijun [1 ]
Yang, Xiaoshan [1 ]
Zhao, Min [1 ]
Shi, Jian [1 ,2 ]
Wang, Ying [1 ,2 ]
Lu, Linlin [1 ]
Liu, Zhongqiu [1 ,2 ]
机构
[1] Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou 510006, Guangdong, Peoples R China
[2] Southern Med Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Guangzhou 510515, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Aconitum alkaloids; Efflux transporters; Multidrug resistance-associated protein 2; MRP2-MDCKII cell; P-GLYCOPROTEIN; CACO-2; MESACONITINE; HYPACONITINE; METABOLITES; TRANSPORT;
D O I
10.1016/j.lfs.2015.02.011
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims: Aconitum alkaloids mainly contain highly toxic aconitine (AC), mesaconitine (MA), and hypaconitine (HA) and less toxic benzoylaconine (BAC), benzoylmesaconine (BMA), benzoylhypaconine (BHA), aconine, mesaconine, and hypaconine. The efflux transporters including P-glycoprotein (P-gp), breast cancer resistance protein (BCRP) and multidrug resistance-associated protein 2 (MRP2) can efflux toxicants to prevent poisoning. Our previous publication has proved that P-gp and BCRP contributed to the efflux of AC, MA and HA, which is demonstrated in the human colonic adenocarcinoma cell lines (Caco-2 cells), Mardin-Darby canine kidney cell lines transfected with MDR1 or BCRP (MDR1-MDCKII and BCRP-MDCKII cells). However, the role of MRP2 remains uncertain. Main methods: The MRP2-MDCKII cells were used to determine the efflux ratios (Er) and intracellular amounts of Aconitum alkaloids. In addition, the importance of MRP2 was further investigated with or without the MRP2 inhibitor, LTC4. Key findings: The Er values of AC, MA, HA, BAC, BMA and BHA in MRP2-MDCKII cells (6.4 +/- 03, 5.9 +/- 0.5,22 +/- 02, 1.6 +/- 03, 1.7 +/- 0.2 and 1.9 +/- 0.2 respectively) were significantly higher than those in MDCKII cells, which were close to 1. In the presence of LTC4, the Er values of AC, MA, HA, BAC, BMA and BHA were reduced to approximately 1 and their intracellular amounts were also significantly increased in MRP2-MDCKII cells. Significance: MRP2 was involved in the efflux of AC, MA, HA, BAC, BMA and BHA, which would be useful for the safe application of these components or their herbs. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 50 条
[31]   Increased Systemic Exposure of Methotrexate by a Polyphenol-Rich Herb via Modulation on Efflux Transporters Multidrug Resistance-Associated Protein 2 and Breast Cancer Resistance Protein [J].
Yu, Chung-Ping ;
Hsieh, Yun-Chung ;
Shia, Chi-Sheng ;
Hsu, Pei-Wen ;
Chen, Jen-Yuan ;
Hou, Yu-Chi ;
Hsieh, Yo-Wen .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (01) :343-349
[32]   Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity [J].
Liu, Chengcheng ;
Janke, Laura J. ;
Yang, Jun J. ;
Evans, William E. ;
Schuetz, John D. ;
Relling, Mary V. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (02) :287-293
[33]   Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in rats [J].
Noda, Takayuki ;
Abe, Fumie ;
Ueyama, Jun ;
Kato, Miki ;
Katoh, Miki ;
Nadai, Masayuki ;
Saito, Hiroko ;
Hasegawa, Takaaki .
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (02) :207-213
[34]   Sorting Nexin 27 Interacts with Multidrug Resistance-associated Protein 4 (MRP4) and Mediates Internalization of MRP4 [J].
Hayashi, Hisamitsu ;
Naoi, Sotaro ;
Nakagawa, Takayuki ;
Nishikawa, Toru ;
Fukuda, Hiroyuki ;
Imajoh-Ohmi, Shinobu ;
Kondo, Ayano ;
Kubo, Kiyotaka ;
Yabuki, Takashi ;
Hattori, Asami ;
Hirouchi, Masakazu ;
Sugiyama, Yuichi .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (18) :15054-15065
[35]   Lipopolysaccharide Increases the Expression of Multidrug Resistance-Associated Protein 1 (MRP1) in RAW 264.7 Macrophages [J].
Silverstein, Peter S. ;
Audus, Kenneth L. ;
Qureshi, Nilofer ;
Kumar, Anil .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2010, 5 (04) :516-520
[36]   Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition [J].
Hanssen, Kimberley M. ;
Haber, Michelle ;
Fletcher, Jamie, I .
DRUG RESISTANCE UPDATES, 2021, 59
[37]   EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) GENE IN NON-SMALL-CELL LUNG-CANCER [J].
OTA, E ;
ABE, Y ;
OSHIKA, Y ;
OZEKI, Y ;
IWASAKI, M ;
INOUE, H ;
YAMAZAKI, H ;
UEYAMA, Y ;
TAKAGI, K ;
OGATA, T ;
TAMAOKI, N ;
NAKAMURA, M .
BRITISH JOURNAL OF CANCER, 1995, 72 (03) :550-554
[38]   The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells [J].
Ye, Ling ;
Yang, Xiaoshan ;
Yang, Zhen ;
Gao, Song ;
Yin, Taijun ;
Liu, Wei ;
Wang, Feng ;
Hu, Ming ;
Liu, Zhongqiu .
TOXICOLOGY LETTERS, 2013, 216 (2-3) :86-99
[39]   Regulation of Expression and Activity of Rat Intestinal Multidrug Resistance-Associated Protein 2 by Cholestatic Estrogens [J].
Arias, Agostina ;
Villanueva, Silvina S. M. ;
Ruiz, Maria L. ;
Luquita, Marcelo G. ;
Veggi, Luis M. ;
Pellegrino, Jose M. ;
Vore, Mary ;
Catania, Viviana A. ;
Mottino, Aldo D. .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (06) :1277-1285
[40]   Reply to: "Impaired expression of multidrug resistance-associated protein 2 and liver damage in erythropoietic protoporphyria" [J].
Bloks, Vincent W. ;
Plosch, Torsten ;
Jonker, Johan W. ;
Kuipers, Folkert .
HEPATOLOGY, 2016, 63 (05) :1743-1744